Abstract

This chapter discusses the perspectives about the use of internal ribosome entry site (IRES) and 2A peptides to create multicistronic vectors for gene and gene and cell therapy and the prevention of various human diseases. IRES-based and 2A peptide-based vectors are promising tools that can be used in combined gene therapy of many rare and/or heterogeneous diseases. Self-cleaving 2A peptides are promising candidates for the production of multicistronic vectors due to their small size and self-cleavage ability. In the field of infectious diseases, multicistronic constructs have so far found use only in the production of preventive vaccines and progress in this area is not expected in the near future. Incomplete cleavage of products of 2A-based multicistronic constructs can lead to a decreased yield of the final product and to the disruption of the protein functions.

Highlights

  • Gene therapy was introduced as having significant potential for the treatment of various diseases

  • To differentiate induced pluripotent stem cells (iPSCs) into insulin-producing cells, iPSCs were co-transduced with multicistronic adenoviral vectors containing the pancreatic and duodenal homeobox-1 (Pdx1), neurogenin 3 (Ngn3), or musculoaponeurotic fibrosarcoma oncogene homolog A (MafA) genes linked through internal ribosome entry site (IRES) to the green fluorescent protein (GFP) reporter gene

  • IRES-based and 2A peptide-based vectors are promising tools that can be used in combined gene therapy of many rare and/or heterogeneous diseases

Read more

Summary

Introduction

Gene therapy was introduced as having significant potential for the treatment of various diseases. The IRES-dependent initiation of translation in various viruses occurs in different ways Due to their specific structures, some IRESs can functionally replace many protein factors and, it is assumed, can bind and modify the ribosome conformation [45,46], which is why the IRES-dependent initiation of translation does not require a complete (or any) eIF set. The translation of all genes which are located downstream of the IRES occurs independently of each other [49], in contrast to vectors containing 2A peptide sequences [32]. A significant advantage of IRES sequences is the complete separation of proteins, whereas the use of 2A peptides can result in incomplete cleavage of the translated polypeptide (Table 1) [50]. Ribosomal skipping occurs after the synthesis of the first gene is complete, synthesis continues without the dissociation of ribosome

Self-Cleaving 2A Peptides
Multicistronic Vectors for Neurodegenerative Disease Therapy
Multicistronic Vectors for Metabolic Disease Therapy
Multicistronic Vectors for the Treatment of Autoimmune Diseases
Multicistronic Vectors for Cardiovascular Disease Therapy
Multicistronic Vectors for Cancer Therapy
Multicistronic Vectors for the Prevention of Viral and Bacterial Infections
10. Conclusions and Future Perspectives
Findings
Clinical Review Report
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.